LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Brought to the industry by Advertise.com developers, the sweeping novelty in the digital marketing world is the groundbreaking text-based banner ads implementation strategy – Adable that helps deliver contextually adequate, text-based ads connected to a website’s actual content. Daniel Yomtobian, Founder and CEO of Advertise.com, notes that the technology has been redesigned by combining both contextual and behavioral data to achieve more engaging advertisements with a higher relevancy to its viewer. With immediate ad delivery based on the content users are already engaging with, Adable ensures a much greater ROI for advertisers, as well as, a more useful set of ads for the user. From a marketing perspective, the product connects the best on both sides of the marketing spectrum for more specific targeted results.

The goal for advertising campaigns is to reach the targeted demographic as directly as possible. This has redefined the entire Internet marketing industry – with companies like Yomtobian’s Advertise.com leading the way in both innovation and results. Old-fashioned Internet-based advertising primarily focused on the cost-per-impression (CPI). Early on, Daniel Yomtobian recognized the problem with traditional CPI payments for banner ads; it inevitably leads to wasted money. In efforts to improve the overall marketing return-on-investment, contextual and relevance-based advertising was introduced. This type of relevance is precisely where Adable can achieve an even better ROI for advertisers. Adable’s contextual advertising product addresses these problems in two important ways. The technology automatically assures that relevant ads are being directly published onto sites that connect with its visitors. Secondly, the platform allows for a seamless integration within a site’s current design. This dual focus permits site owners to interweave the Adable technology into their websites without disrupting the user experience. Users are able to enjoy the site they’re visiting – while seeing contextually relevant, non-intrusive text-based ads.

Adable’s customizable platform offers an impressive range of benefits for advertisers. It allows for a variety of different ad sizes for simple integration with any page layout. Ad unit sizes range from 728×90 to 300×600 in any combination advertisers require. Beyond the dimensions, advertisers can also customize the ad unit with multiple color options for title, text, and arrows to match a site’s color scheme. The ads can even seamlessly integrate within mobile-optimized sites, meaning they will reach their targeted audience no matter where they are. Finally, the competitive CPI yields excellent results for advertisers across a breadth of industries. According to Daniel
Yomtobian, all of these benefits come together to create a better user experience for site visitors. This level of engagement also yields a better result for marketing campaigns.

Daniel Yomtobian originally founded Advertise.com in 2001, and since then the company has grown into the world’s largest privately held keyword pay-per-click (PPC) network. Yomtobian is proud of his company’s success, “We launched Advertise.com to provide advertisers and publishers a new value proposition — effective, affordable, and easy-to-use advertising campaigns all under one roof.” From his early start as a web designer and Internet marketer, Daniel Yomtobian has helped thousands of businesses drive targeted visitors to their websites. Today, Daniel is considered a pioneer in the online advertising industry and was recently described by C-Suite Quarterly as a “…young leader [who] will continue to play an important role in shaping the online world of tomorrow.”

Daniel Yomtobian – Ernst Entrepreneur of Online Advertising: http://www.DanielYomtobianInfo.com
Daniel Yomtobian – CEO & Founder @ Advertise.com – crunchbase: https://www.crunchbase.com/person/daniel-yomtobian

Our Team – Advertise.com: http://www.advertise.com/our-team/

Contact Information:

DanielYomtobianInfo.com
www.danielyomtobianinfo.com
Daniel@danielyomtobianinfo.com

SOURCE: Daniel Yomtobian

ReleaseID: 456152

NEW YORK, NY / ACCESSWIRE / February 27, 2017 / Encouraged by the rapid growth in the U.S. real estate prices by more than 25% since 2012, a lot of business-minded individuals who are relatively new in the housing industry have made an informed decision to become property investment experts. Paired with record-breaking low interest rates, the opportunity to make a considerable profit is an alluring one. Of course, like any new venture, it pays – literally – to learn as much about the art and strategy of buying real estate as possible. Renowned New York-based property expert and investment consultant Jacob
Frydman has spent more than thirty years honing his successful business and has discussed a few tips that will help new investors who are entering the market.

There are a multitude of factors that determine real estate value, and the investors who consistently see returns are the ones who take time to educate themselves about all aspects, says Jacob
Frydman. They know the location and the history of the place, because understanding what drove the early development or the area is a key way to find potential neighborhoods that may have been forgotten and potentially undervalued here in the present.

Evaluating the overall local economy and assessing current growth trends is a vital component to successful property investing. Is the population growing, and in which parts of town? What new developments are planned that will likely spur additional growth and boost land values? What are the transportation issues in the area? Is there substantial infrastructure for the future population or will the local government need to expand roads or add rail lines – which usually means increasing real estate taxes and tends to make neighborhoods outside those municipal boundaries more attractive to residents and businesses.

The most important piece of advice which ultimately guides everything else, says Jacob Frydman, is “to always treat your business like a business, and not a hobby. Real estate investing is a matter of cash flow, balances and long-term planning, it is not an emotional transaction, the way buying your primary residence may have been.” It is essential to write a business plan that covers one, three, five and ten years. Create systems, process and rules that guide you like clockwork, objectively rather than subjectively.

Jacob
Frydman is a New York-based real estate consultant who sources and identifies value-added investment opportunities. For more than 30 years, he has successfully executed highly complex real estate transactions valued at over $2 billion and spanning over 5 million square feet. In addition to lecturing on real estate finance at Columbia University and New York Law School, Frydman is a frequent guest on CNBC, Bloomberg TV, Fox News and other major TV news outlets. An avid philanthropist, Jacob Frydman devotes much of his time and capital to various charitable organizations, including the National Committee for Furtherance of Jewish Education (NCFJE), Chabad of Dutchess County, and the Brem Foundation of Washington, DC.

Jacob Frydman – Blog – JacobFrydmanNews.com: http://JacobFrydmanNews.com
Jacob Frydman — Huffington Post: http://www.huffingtonpost.com/author/jacob-frydman
Jacob Frydman – Examines NYC’s Zoning for Mixed-Use Commercial and Residential Real Estate: http://finance.yahoo.com/news/jacob-frydman-examines-nycs-zoning-224500689.html

Contact Information:

JacobFrydmanNews.com
contact@jacobfrydmannews.com
www.JacobFrydmanNews.com

SOURCE: Jacob Frydman

ReleaseID: 456150

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Rentech, Inc. (“Rentech” or the “Company”) (NASDAQ: RTK). Investors who purchased or otherwise acquired Rentech shares between November 9, 2016, and February 20, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 24, 2017 lead plaintiff deadline.

If you purchased shares of Rentech during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On February 21, 2017, Rentech stated it would slow its Wawa facility due to equipment and operational problems that would need more unbudgeted capital investments. Rentech also noted “continued uncertainty” concerning the profitability of pellets made at the facility and told investors that it was experimenting with alternatives for both the Wawa facility and Rentech.

When this information was revealed to the investing public, the value of Rentech fell significantly, causing investors harm.

If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456141

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Stemline Therapeutics, Inc. (“Stemline” or the “Company”) (NASDAQ: STML) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired Stemline shares between January 19, 2017 and February 1, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 4, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

On February 2, 2017, Bloomberg confirmed that a patient undergoing a clinical trial of Stemline’s cancer drug SL-401 died from a severe side effect, the third death related to SL-401 toxicity.

When this information was revealed to the public, the value of Stemline stock fell sharply, causing investors serious harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456139

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Kitov Pharmaceuticals Holdings Ltd. (“Kitov” or the “Company”) (NASDAQ: KTOV). Investors, who purchased or otherwise acquired Kitov shares between November 20, 2015 and February 3, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 10, 2017 lead plaintiff deadline.

If you purchased shares of Kitov during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On February 6, 2017, the Israeli publication Calcalist disclosed that Kitov’s Chief Executive Officer, Isaac Israel, had been detained by the Israeli Securities Authority due to allegations of publishing misleading information regarding a recent clinical trial of one of Kitov’s products. When this information was announced to the public, the value of Kitov stock fell, causing investors harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456140

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against ReWalk Robotics Ltd (“Rewalk” or the “Company”) (NASDAQ: RWLK). Investors, who purchased or otherwise acquired Rewalk shares pursuant and/or traceable to the Company’s Stock Offering on or about September 12, 2014, are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.

If you purchased shares of ReWalk during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

The Complaint alleges that the Registration Statement and Prospectus issued in regards with the Initial Public Offering did not disclose material information, including that ReWalk could not comply with “special controls” requirements or to offer the U.S. Food and Drug Administration with a postmarket surveillance study. When this information was announced to the public, the value of Rewalk fell, causing investors serious harm.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456138

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against (“OneMain” or the “Company”) (NYSE: OMF). Investors, who purchased or otherwise acquired OneMain shares between March 3, 2015, and November 7, 2016, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

OneMain develops, markets, and sells financial products through its subsidiaries. On November 7, 2016, OneMain announced unsatisfactory third quarter financial results. When this information was revealed to the investing public, the value of OneMain stock fell nearly 40%, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456135